CLRB Competitors & Alternatives
Compare Cellectar Biosciences Inc with similar stocks in the same industry
Biotechnology
CLRB
Main Stock$2.21
Tradestie Score
51
Market Cap
$18.42M
Analyst Upside
+367.6%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACHV
Achieve Life Sciences, Inc.
|
$5.48
|
$158.43M | - | 59 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.19
|
$133.50M | - | 56 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$20.78
|
$110.20M | - | 54 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.52
|
$71.69M | - | 59 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.66
|
$67.94M | - | 54 | Compare |
|
TENX
Tenax Therapeutics, Inc.
|
$11.35
|
$34.77M | - | 55 | Compare |
|
MBRX
Moleculin Biotech, Inc.
|
$2.72
|
$26.23M | - | 56 | Compare |
|
PULM
Pulmatrix, Inc. Common Stock
|
$1.48
|
$17.88M | - | 57 | Compare |
|
BLRX
BioLineRX Ltd
|
$3.15
|
$16.50M | - | 50 | Compare |
|
HEPA
HEPA
|
- | - | - | - | Compare |
More CLRB Analysis
Data updated: Jun 16, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry